Novitium’s Pyridostigmine Shows Six Appeal Of CGT Pathway
In granting its sixth approval for an ANDA with a Competitive Generic Therapy (CGT) designation, the FDA insists it is fostering competition in the US off-patent market.
You may also be interested in...
After receiving a CGT designation by the FDA for its generic version of Amicar, Amneal gets 180 days of exclusivity.
Dr Reddy’s will be alone in the US market for six months with the first generic rival to Pfizer’s Hemabate carboprost brand.
Bringing in a minority investor for its Glenmark Life Sciences raw materials unit and divesting non-core products are among the strategic priorities for Glenmark in its current financial year ending in March 2020.